Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project.
Wennan LiuZiping LiTianqi YangGeru AHaonan SunHangkuan LiuXiwen SongZhengyang JinLinjie LiYongle LiYongchen HaoJing LiuDong ZhaoXin ZhouQing Yangnull nullPublished in: Cardiovascular drugs and therapy (2022)
In a nationwide registry, routine use of GPI following thrombus aspiration was not associated with reduced in-hospital ischemic events and mortality but at the cost of increased major bleeding. However, for patients aged < 60 years, there may be a potential net benefit.
Keyphrases
- st elevation myocardial infarction
- end stage renal disease
- percutaneous coronary intervention
- healthcare
- ejection fraction
- coronary artery disease
- chronic kidney disease
- newly diagnosed
- acute coronary syndrome
- coronary artery
- acute care
- prognostic factors
- peritoneal dialysis
- type diabetes
- quality improvement
- cardiovascular events
- adverse drug
- metabolic syndrome
- cardiovascular disease
- adipose tissue
- oxidative stress
- aortic stenosis
- emergency department
- ischemia reperfusion injury
- risk assessment
- insulin resistance
- climate change
- human health
- subarachnoid hemorrhage